China's Health System Reforms Are Opening Gates To Creating Gigantic Pharmacy Chains, Says One Would-be Titan
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The first phase of Beijing's healthcare reforms, centered on expanding medical facilities across the hinterland and extending insurance coverage to rural residents, is creating massive opportunities for drug retailers to form giant chain stores to march through and occupy the Chinese countryside, say the leaders of would-be giant BioPharm Asia
You may also be interested in...
Squeezed by Price Caps And Rising Costs, China's Nepstar Drugstore Chain Pushes Its Own Brands
Want to get beverages on a drug store run for aspirin in China? Not a problem in Nepstar stores, where China's largest retail pharmacy chain is increasingly becoming more of a convenience store than a traditional drug store. It is shifting its business model to focus on private label products to fend off a double squeeze: swelling rental and labor costs and ongoing governmental reform initiatives to impose price caps on drug retailers
Squeezed by Price Caps And Rising Costs, China's Nepstar Drugstore Chain Pushes Its Own Brands
Want to get beverages on a drug store run for aspirin in China? Not a problem in Nepstar stores, where China's largest retail pharmacy chain is increasingly becoming more of a convenience store than a traditional drug store. It is shifting its business model to focus on private label products to fend off a double squeeze: swelling rental and labor costs and ongoing governmental reform initiatives to impose price caps on drug retailers
Liver Cancer Drug Market To Triple By 2014; MNCs Will Take Lead
SHANGHAI - Sales of hepatocellular carcinoma drugs in China will nearly triple from $53 million in 2009 to $144 million in 2014, a new research report from Decision Resources found